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Summary This is the second report of a large case control study of lymphoma/leukaemia occurring in
Yorkshire during 1979-84, and deals with chronic lymphocytic leukaemia presenting either in its haemato-
logical (CLL) or more solid lymphomatous (malignant lymphoma-lymphocytic or MLL) forms. In all, 330
cases and 561 controls were interviewed. The results support the concept that CLL/MLL is a condition of
multiple aetiologies with evidence for genetic predisposition through an excess of family cases, immune
perturbation demonstrated by excessive previous skin diseases and phenylbutazone use, and viral involvement
shown by links with infectious diseases and multiple sclerosis.
The aetiology of chronic lymphocytic leukaemia (CLL) has All data were coded and validated by a separate trained
been inadequately investigated in previous epidemiological group of staff and analysed using the statistics incorporated
studies and has been confused further by its inclusion with in the programs of Rothman and Boice (1982), using
other forms of leukaemia unrelated in terms of the purported stratified techniques and the age groups <70 years and > 70
cell of origin. In this study we have separated CLL from years by sex and by CLL vs. MLL. Rarer responses and a
other forms of leukaemia and included cases presenting with preliminary analysis resulted in the pooling of data giving
the related solid lymphomatous forms of disease - ML crude risk ratios.
lym-phocytic (MLL). From the results of previous studies
(Bcrnard et al., 1984; 1987) we have pursued the hypothesis
that this condition is the result of interactions between Results
aspects of inherent susceptibility and unknown infectious
agents. No results reported in this paper have been used in Non-significant or unassessable risks
the pilot survey described by Bernard et al. (1984). Table I lists those interview topics for pooled CLL and MLL
cases with 5 or less case or control responses. These topics
Methods and population
are not considered further, because although there are a few
absolute associations (electrical workers, radio mechanics
Cases diagnosed in the Yorkshire Health Region between and past chemotherapy), with such small numbers it is
October 1979 and December 1984 were eligible for inclusin, *difficult to make a proper assessment of significance. Topics October 199 and Deceber 1984 w re-lgbefricuin which produced no response in either cases or controls are In total 245 cases of CLL and 85 cases of its lymphomatous
form (MLL) were interviewed together with 423 and 138 not given.
controls respectively. The hospital notes of every case aTable II gives, in summary, interview topics which show
controlswrespetively. but hosP notes ofr case risk ratios less than 2.0 without statistically significant excess
cases and 17 controls. These interviewseprpesent over 80% at 5% or less. Further analysis of results grouped by sex,
ofalelgbcases anes interviews pset over 80% haematogenous or solid form of disease or age, shows no of~~~~~ al elgil cae.gdudr7 adjs vr5%o statistical excesses or deficits which may have been obscured
those older than this. The non-interviewed cases tended to
come from more distant parts of the region in North by pooling.
Yorkshire and Humberside and in most instances were
people who had died prior to contact being made to arrange Table I Chronic lymphocytic leukaemia: Case
an interview. control study: Unassessable responses: 5 or less
A detailed description of the methods used in this study case or control responsesa
are given in a previous paper (Bernard et al., 1987). Briefly
the study established its own method of case ascertainment Past medical history
and diagnosis within the Yorkshire Health Region. Trained Allergy to soap 3, 3b
interviewers using one standard questionnaire visited all Hyperthyroidism 4, 5
cases and controls. A hospital based control population was Quinsy 5, 3
used after a study contrasting such a group with neighbour-
i
hood controls showed little difference in those 20 responses Drug ingestion Chemotheranv in nast 3, 0 analysed. The hospital controls were chosen from a wide Chemthernapy in paSt3, 0
variety of wards and were mainly accident admissions or Anti TB drugs 2, 4
awaiting cold surgery. No control was admitted for a Fml lnse
malignant disease. A case control matching ratio of 1:1.7 Faiypilertyodsses ,
was achieved and interview responses regarding medical Ocptoa ru
information were cross checked with medical records either Ruadiographr0,ou1
from general practitioners or hospitals. Electrical workers 5, 0
Radio mechanics 3, 0
*Present address: Department of Pathology, University of Photographic industry workers 2, 5
Edinburgh Medical School, Edinburgh EH8 9AG, UK.
Correspondence: R.A. Cartwright. aCLL and MLL data pooled; bNumber of
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Table II Chronic lymphocytic leukaemia: Case before diagnosis is almost the same in as the control
control study: Topics giving on-significant population. The herpes zoster infections are specifically
response and having risk ratios under 2.0 linked with the CLL subgroup (i.e. excluding MLL).
Past medical history Drug ingestion A strong association was also observed with migraine
almost exclusively in women (P=0.008) and with heart
TB 17, 127a Amphetamines 11, 20 disease especially hypertension and myocardial infarction in
Allergy 67, 150 Contraieption 6, 10 men (P=0.01). However no excess of cigarette smoking was
Tonsillertomy 74, 128 Antibiotios 19, 23 associated with any of the case subgroups (overall RR=0.8,
Infectious mononuildosis 2 7 Analgesics 43, 78 P=0.19). Finally osteoarthritis in females with CLL
Malaria 12, 11 Other antinausea drug 9 9 excluding MLL proved a significant risk factor (RR=2.1,
Diabetes 12, 15 Antacids 28, 49 P=0.04), but not in males.
Psychiatric disorder 22, 41 Benzodiazepine 68. 110
Epilepsy 3, 7 Anticonvulsant 9, 16 Past therapy
Rheumatic fever 11, 11 Anti-inflammatory 55, 82
Pneumonia 7, 11 Bronchodilators 15, 31 Table V summarizes some risks linked with previous therapy.
Gastric ulcer 11, 13 Steroids 25, 51 The risks associated with past radiotherapy may be due to
Duodenal ulcer 14, 32 Endocrine 9, 10 treatment for skin malignancies or internal solid tumours
Rheumatoid arthritis 9, 19 and would depend on the dose received by circulating
Osteoarthritis 29, 45 Family illnesses lymphocytes. The association with drugs used to treat
Vertigo 13, 14 Confirmed cancer in relations 56, 83 arterial conditions seems likely to be related to the excess of
Diagnostic X-ray 296, 511 Infectious mononucleosis 12, 14 heart disease and hypertension already noted. Although a
Dental anaesthesia 51, 177 TB 31, 50 wide variety of drugs was involved, only digoxin showed
Occupation Rheumatoid arthritis 6, 19 significant associations (P=0.04). Finally phenylbutazone Diabetes 34, 52 showed a strong association (P=0.006) when taken within
Farming 54, 78 Asthma 40, 58 10 years of diagnosis of CLL/MLL for various arthritic
Mining 22, 33 Eczema/dermatitis 11, 12 conditions. No significant risk could be found for other anti-
Chemical worker 23, 47 Psoriasis 4, 6 infltory drus.
Glass industry worker 4, 9 inflammatory drugs.
Furnace, forge worker 12, 24 Social characteristics
Engineer 81, 130 Jews 5, 7 Familial diseases
Woodworker 14, 34 Sibship sizeb The results for associated family illnesses are shown in Table
Textile worker 73, 132 Cigarette smoker 197, 292C VI. The association with other malignancies is confined to
Clothing worker 38, 76 Spinrt drinker 37, 77 blood relations. Overall there is a weak familial excess due to
Food industry 44, 69 Pet owner 263, 448 a variety of lymphoid and myeloid malignancies. Although
Printer 11, 30 Foreign travel 140 304 most risks are greater than unity no significant excess is
Construction industry 29, 47 g achieved.
Painters 7, 16 There is a clear excess of cases with a family history of
Labourer 10, 14 multiple sclerosis (MS). This incorporates both spouses and
Transport worker 52, 95 first degree blood relatives. Unlike the link with leukaemia,
Warehouse 5, 17 this excess is not confined to blood relations: two spouse
Clerical work 39, 56
Sales work 92, 166 pairs were observed although the majority of this association
Service industries 101, 198 is due to sib pairs.
Professional worker 18, 43
Armed Forces 83, 154 Social and occupationalfactors
aNumber of positive cases, control responses; bVarious com- There were no significant excesses in social characteristics
parisons i.e. 0+1 versus 2+ and 0 versus 1+ and 0, 1, 2, 3 versus nor any occupational links except for the small absolute
3+ etc.; CVersus modified controls, i.e. the control group, elimin- excess of electrical workers referred to previously.
ating those controls with smoking related conditions at time of
interview.
Discussion
Skin diseases The results of this study tend to support a multifactorial
aetiology in the production of these malignancies and in
As shown in Table III no excess risk is associated with a general risks are common to both the haematogenous and
previous history of eczema/dermatitis and the excess risks solid lymphomatous forms of the disease.
shown for other skin conditions are largely confined tohe The association found by Linos (1981) and Karchmer et
CLL group excluding MLL. The excess risk is due largely to al. (1974) between skin cancers and these conditions, not
past skin malignancies of several histopathological types and confined to the radiotherapy treated group, has been
treatment by radiotherapy or other steroids increases the confirmed. However, no temporal link between skin cancer
risk. and CLL/MLL has been established and may be due to
common aetiological factors rather than sequential steps in
Past medical conditions the leukaemic process. Skin repair mechanisms and other
A history of past malignancy (excluding skin cancers) pro- aspects of skin immunity may be important although this
duced an overall twofold risk (RR=2.69, P=0.002) confined study has not revealed excesses of malignancy in groups who
largely to the CLL group excluding MLL. No one solid might be supposed to have excessive exposure to sunlight,
tumour type accounted for this excess. such as farmers.
Table IV gives pooled results for other past medical It might also be deduced from our results that systemic
conditions. There is a significant negative relationship with and skin immunity may be impaired from the association
past appendectomies. With this exception all other associa- found with herpes zoster infection which was also reported
tions show significant excesses particularly with various in the tristate study (Gibson et al., 1976) where, in addition,
forms of past infection. These infections normally predate an association with 'rheumatism' and arthritis was noted.
the diagnosis of CLL/MLL by many years. However, herpes Unlike other work no link with rheumatoid arthritis was
zoster infections are more common within 2 years of CLL & found. Of the other infections that show excesses in this
MLL diagnosis, whilst its appearance more than 5 years study chronic bronchitis and chronic ear infection are novelEPIDEMIOLOGY OF CLL IN YORKSHIRE 81
Table III Chronic lymphocytic leukaemia: Case control study: Association with past skin
conditions
No. No. RR 95% confidence 2 tail
Eczema/dermatitis cases controls limit P
CLL Male 16 26 1.0 0.5-2.0 0.91
Female 13 18 1.3 0.6-2.8 0.47
MLL Male 5 11 0.7 0.2-2.3 0.61
Female 5 7 1.1 0.3-3.9 0.84
All other skin conditionsa
CLL Male 26 15 3.4 1.8-6.5 <0.001
Female 13 16 1.5 0.7-3.3 0.29
MLL Male 4 8 0.8 0.2-2.9 0.77
Female 6 6 1.6 0.5-5.5 0.42
Basal cell carcinoma
CLL Male 7 2 6.6 1.6-26.2 0.008
Female 6 3 3.6 0.9-13.5 0.06
Other skin cancers
CLL Male 4 0 a
Female 2 1 a
Any skin cancer with
radiotherapy
CLL Male and
Female 6 1 11.1 2.0-60.2 0.006
Any skin cancer without
radiotherapy
CLL Male and
Female 13 5 4.8 1.9-12.4 0.002
'Too few numbers for analysis; bIncluding skin cancer.
Table IV Chronic lymphocytic leukaemia: Case control study: Past medical historya
95%
No. No. confidence 2 tail
Condition cases controls RR limits P
Appendectomy 52 125 0.7 0.5-0.9 0.02
Migraine 10 4 4.4 2.0-12.7 0.008
Scarlet fever 11 6 3.2 1.2-8.3 0.02
Herpes zoster 36 34 1.9 1.2-3.1 0.01
Diagnosed 0-1 ears 8 4 3.6 1.2-11.2 0.02
2-4 Ye s 8 6 2.4 0.9-6.7 0.10 52+ previously 17 23 1.3 0.7-2.5 0.39
Chronic ear infection 23 21 1.9 1.1-3.5 0.03
Bronchitis 21 17 2.2 1.2-4.1 0.02
All heart disease includes: 62 71 1.6 1.1-2.3 0.01
Hypertension 37 41 1.6 1.0-2.6 0.04
Myocardial infarction 15 13 2.0 1.0-4.2 0.05
Past malignancy 24 16 2.7 1.4-5.0 0.002
apooled sexes, pooled diagnosis.
Table V Chronic lymphocytic leukaemia: Case control study: Past
medical treatmenta
95%
No. No. confidence 2 tail
Condition cases controls RR limit P
Past radiotherapy 16 10 2.8 1.3-6.1 0.01
Antihypertensives
and diuretics and
related drugs 91 114 1.5 1.1-2.1 0.01
Phenylbutazone
within 10 years of
diagnosis 27 21 2.2 1.3-4.0 0.006
apooled sexes, pooled diagnosis.82 R.A. CARTWRIGHT et al.
Table VI Chronic lymphocytic leukaemia: Case control study:
Family historya
95%
No. No. confidence 2 tail
Condition cases controls RR limit P
Lymphoma or leukaemia
in families 20 20 1.8 0.9-3.3 0.08
CONFIRMED CASES:
NHL in families 4 2 3.4 0.7-17.1 0.13
HD in families 3 7 0.7 0.2-2.8 0.64
Lymphoid leukaemia
in families 5 2 4.3 0.9-19.5 0.13
Myeloid leukaemia
in families 4 2 3.4 0.7-17.1 0.77
'Other' leukaemia
in families 5 7 1.2 0.4-3.9 0.73
Multiple sclerosis
in families 15 11 2.4 1.1-5.2 0.03
apooled sexes, pooled diagnosis.
observations, whilst scarlet fever (often many years ago) was
previously observed in the pilot study (Bernard et al., 1984).
An interesting possible new link with migraine was observed
but other conditions, such as asthma or eczema, were not
shown to be in excess contrary to our pilot study results
(Bernard et al., 1984) and one report from elsewhere
showing an association with eczema (Gibson et al., 1976).
The association between heart disease and treatment with
related drugs is new and unexpected. It was asserted many
years ago that phenylbutazone may be linked with leukaemia
induction due to its noxious side-effects but when this was
critically addressed by a case control study by Friedman
(1982) he showed a link with prior musculoskeletal diseases
rather than treatment. In our study phenylbutazone had
mainly been prescribed for arthritic conditions occurring
some time prior to diagnosis and usually described as osteo-
arthritis.
The familial links with CLL have been reported before
(Gunz et al., 1975; Conley et al., 1980). In this survey the
most common relationship is in sib pairs. No excess of cases
in Jewish patients was observed although this was found in
the pilot study (Bernard et al., 1984) along with other
lymphomas and has been described in other reports (Bartal
et al., 1978).
The possible link with MS has been reported elsewhere
(Bernard et al., 1986) and might be relevant to the
observation by Koprowski et al. (1985) who have claimed to
find HTLV-like sequences in spinal fluid leucocytes from
sufferers of MS. Broad parallels can also be drawn with MS
where cases appear to have increased numbers of prior
infections notably acquired at older ages (Phadke & Downie,
1987).
The view that these malignancies arise because of genetic
susceptibility associated with some form of immune pertur-
bation and infective disorder is supported by the following
observations in this study: Genetic susceptibility is par-
ticularly linked to the increased incidence of the malignancies
observed in families. The association with immune pertur-
bation is supported by the occurrence of excess prior skin
and other internal malignancies, possibly indicating a
lowering of normal immune surveillance and the excess of
chronic and severe infections. Finally the link with infectious
agents is supported by the relation with MS and a variety of
infections.
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Startin and Brenda Waller who have worked for several years with
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